Nakajima A - Search Results

1

A massive intraventricular thrombosis by disseminated mucormycosis in a patient with myelodysplastic syndrome during deferoxamine therapy.

Kubota N, Miyazawa K, Shoji N, Sumi M, Nakajima A, Kimura Y, Oshiro H, Ebihara Y, Ohyashiki K. Kubota N, et al. Among authors: nakajima a. Haematologica. 2003 Sep;88(9):EIM11. Haematologica. 2003. PMID: 12969824 No abstract available.

2

A massive intraventricular thrombosis by disseminated mucormycosis in a patient with myelodysplastic syndrome during deferoxamine therapy.

Kubota N, Miyazawa K, Shoji N, Sumi M, Nakajima A, Kimura Y, Oshiro H, Ebihara Y, Ohyashiki K. Kubota N, et al. Among authors: nakajima a. Haematologica. 2003 Nov;88(11):EIM13. Haematologica. 2003. PMID: 14607766 No abstract available.

3

Telomere dynamics in myelodysplastic syndrome determined by telomere measurement of marrow metaphases.

Sashida G, Ohyashiki JH, Nakajima A, Sumi M, Kawakubo K, Tauchi T, Ohyashiki K. Sashida G, et al. Among authors: nakajima a. Clin Cancer Res. 2003 Apr;9(4):1489-96. Clin Cancer Res. 2003. PMID: 12684424

4

Efficacy of SCH66336, a farnesyl transferase inhibitor, in conjunction with imatinib against BCR-ABL-positive cells.

Nakajima A, Tauchi T, Sumi M, Bishop WR, Ohyashiki K. Nakajima A, et al. Mol Cancer Ther. 2003 Mar;2(3):219-24. doi: 10.4161/cbt.2.3.390. Mol Cancer Ther. 2003. PMID: 12657715

5

Natural killer cell lymphoma in the duodenum.

Sumi M, Tauchi T, Sashida G, Kuriyama Y, Nakajima A, Mukai K, Ohyashiki K. Sumi M, et al. Among authors: nakajima a. Leuk Lymphoma. 2003 Jan;44(1):201-4. doi: 10.1080/1042819021000054706. Leuk Lymphoma. 2003. PMID: 12691165

6

BCL-2 antisense oligonucleotide genasense is active against imatinib-resistant BCR-ABL-positive cells.

Tauchi T, Sumi M, Nakajima A, Sashida G, Shimamoto T, Ohyashiki K. Tauchi T, et al. Among authors: nakajima a. Clin Cancer Res. 2003 Sep 15;9(11):4267-73. Clin Cancer Res. 2003. PMID: 14519654

7

A clustered dense body in a patient with splenic lymphoma with villous lymphocytes.

Nakajima A, Kawakubo K, Kuriyama Y, Miyauchi J, Ohyashiki K. Nakajima A, et al. Haematologica. 2001 Jan;86(1):109-10. Haematologica. 2001. PMID: 11146585 No abstract available.

8

[Chronic myeloid leukemia associated with sustained severe pancytopenia after imatinib mesylate therapy].

Sumi M, Tauchi T, Shimamoto T, Sshida G, Nakajima A, Ito Y, Ohyashiki K. Sumi M, et al. Among authors: nakajima a. Rinsho Ketsueki. 2002 Sep;43(9):868-70. Rinsho Ketsueki. 2002. PMID: 12412295 Japanese.

9

Detection of Epstein-Barr virus in a pyothorax-associated lymphoma with T-cell phenotype.

Kuriyama Y, Nakajima A, Shimizu N, Ohyashiki JH, Mukai K, Ohyashiki K. Kuriyama Y, et al. Among authors: nakajima a. Haematologica. 2002 Aug;87(8):ECR28. Haematologica. 2002. PMID: 12161375 Review. No abstract available.

10

Activity of a novel G-quadruplex-interactive telomerase inhibitor, telomestatin (SOT-095), against human leukemia cells: involvement of ATM-dependent DNA damage response pathways.

Tauchi T, Shin-Ya K, Sashida G, Sumi M, Nakajima A, Shimamoto T, Ohyashiki JH, Ohyashiki K. Tauchi T, et al. Among authors: nakajima a. Oncogene. 2003 Aug 14;22(34):5338-47. doi: 10.1038/sj.onc.1206833. Oncogene. 2003. PMID: 12917635

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,183 results

Search Page

Filters